Jan Broder Engler studied medicine at the Charité Berlin and the University of Córdoba in Spain. Fascinated by how immune responses are regulated, he joined the Group of Cell Autoimmunity at the German Rheumatism Research Centre Berlin (DRFZ) and received his MD for his work on autoreactive T cells in lupus in 2010. For gaining deeper mechanistic understanding of how immune tolerance can be restored, he joined the INIMS in 2011 and received his PhD of Human Biology in 2015 and the Dr. Martini Prize 2018 for his work on mechanisms of pregnancy-induced immune tolerance. Driven to identify genuine neuroprotective treatment strategies, Broder switched to neurobiology and systems biology to understand how neurons cope with inflammation. In 2020 he became a fellow in the Hertie Network of Excellence in Clinical Neuroscience and in 2021 a Senior Scientist at the INIMS. Currently, Broder explores genetic and epigenetic treatment strategies to empower neurons to fight back inflammation.
Link to Pubmed